Literature DB >> 12322801

Antiphospholipid syndrome treated with prednisolone, cyclophosphamide and double-filtration plasmapheresis.

Shigeru Otsubo1, Kosaku Nitta, Wako Yumura, Hiroshi Nihei, Noriko Mori.   

Abstract

A case of antiphospholipid syndrome (APS) is reported. A 48-year-old man visited our hospital because of proteinuria. He had suffered from thrombosis and had high titers of antibodies to beta2-glycoprotein I (abeta2GPI) and anticardiolipin antibodies (aCLIgG) and thrombocytopenia. We started anticoagulation therapy using warfarin combined with prednisolone. Although platelet count was improved, the titers of anti-beta2GPI and aCLIgG still remained high. Therefore, double-filtration plasmapheresis (DFPP) was carried out to remove the antibodies. After the treatment with DFPP, cyclophosphamide was administered. These therapies resulted in lower titers of abeta2GPI and aCLIgG and no more thrombosis occurred. A combination therapy using warfarin, prednisolone, cyclophosphamide and DFPP might be effective for the treatment of patients with APS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12322801     DOI: 10.2169/internalmedicine.41.725

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Successful plasma exchange combined with rituximab therapy in aggressive APS-related cutaneous necrosis.

Authors:  Rubens Costa; Salman Fazal; Robert B Kaplan; Joel Spero; Ricardo Costa
Journal:  Clin Rheumatol       Date:  2010-06-17       Impact factor: 2.980

2.  Changes in Water Properties in Human Tissue after Double Filtration Plasmapheresis-A Case Study.

Authors:  Felix Scholkmann; Roumiana Tsenkova
Journal:  Molecules       Date:  2022-06-20       Impact factor: 4.927

Review 3.  Osteonecrosis secondary to antiphospholipid syndrome: a case report, review of the literature, and treatment strategy.

Authors:  Waqar Haque; Huseyin Kadikoy; Omar Pacha; Joseph Maliakkal; Vu Hoang; Abdul Abdellatif
Journal:  Rheumatol Int       Date:  2009-12-12       Impact factor: 2.631

4.  Plasmapheresis in a patient with antiphospholipid syndrome before living-donor kidney transplantation: a case report.

Authors:  Tadashi Sofue; Yushi Hayashida; Taiga Hara; Kazuyo Kawakami; Nobufumi Ueda; Yoshio Kushida; Masashi Inui; Hiroaki Dobashi; Yoshiyuki Kakehi; Masakazu Kohno
Journal:  BMC Nephrol       Date:  2014-10-15       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.